3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
13
Obesity
6
Weight Loss
5
Overweight
3
Menstruation Disturbances
2
Intermittent Fasting
2
Insulin Resistance
2
Tumor Surgery
1
Sarcopenia
1
Postoperative Complications
1
Obesity, Abdominal
1
Muscle Weakness
1
Motor Activity
1
Moderately Overweight Individuals
1
Metabolic Syndrome
1
Metabolic Diseases
1
Infertility
1
Glucocorticoid Receptor Deficiency
1
Fasting
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Breast Cancer Female
1
Body Weight
1
Interventions
Clomiphene
21
Metformin
14
Letrozole
11
cetrorelix
6
Triptorelin Pamoate
6
Menotropins
5
Inositol
5
follitropin alfa
4
Folic Acid
4
Chorionic Gonadotropin
4
Sperm Injections, Intracytoplasmic
3
Medroxyprogesterone Acetate
3
ulipristal acetate
2
follitropin beta
2
Uterine Myomectomy
2
Therapeutics
2
Sugars
2
Psychiatric Rehabilitation
2
Progestins
2
Liraglutide
2
Goserelin
2
Gonadotropins
2
Flutamide
2
Fertilization in Vitro
2
Dydrogesterone
2
Cyclophosphamide
2
Counseling
2
testosterone undecanoate
1
methyl N-acetylsibirosaminide
1
drospirenone and ethinyl estradiol combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Infertility
×
Caloric Restriction
×
Clear all
NCT01716429
2019-04-18
HER Health
University of South Carolina
Phase NA
Withdrawn